ZA200700684B - Tricyclic indeno-pyrrole derivatives as serotonin receptor modulators - Google Patents
Tricyclic indeno-pyrrole derivatives as serotonin receptor modulatorsInfo
- Publication number
- ZA200700684B ZA200700684B ZA200700684A ZA200700684A ZA200700684B ZA 200700684 B ZA200700684 B ZA 200700684B ZA 200700684 A ZA200700684 A ZA 200700684A ZA 200700684 A ZA200700684 A ZA 200700684A ZA 200700684 B ZA200700684 B ZA 200700684B
- Authority
- ZA
- South Africa
- Prior art keywords
- receptor modulators
- serotonin receptor
- pyrrole derivatives
- indeno
- tricyclic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/90—Benzo [c, d] indoles; Hydrogenated benzo [c, d] indoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/58—[b]- or [c]-condensed
- C07D209/70—[b]- or [c]-condensed containing carbocyclic rings other than six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Addiction (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US59204704P | 2004-07-29 | 2004-07-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200700684B true ZA200700684B (en) | 2008-10-29 |
Family
ID=37075566
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200700684A ZA200700684B (en) | 2004-07-29 | 2007-01-24 | Tricyclic indeno-pyrrole derivatives as serotonin receptor modulators |
Country Status (16)
Country | Link |
---|---|
US (5) | US20060025601A1 (fr) |
EP (1) | EP1841738A4 (fr) |
JP (1) | JP4990164B2 (fr) |
KR (2) | KR101257233B1 (fr) |
CN (1) | CN101516372A (fr) |
AR (1) | AR050274A1 (fr) |
AU (1) | AU2005333518B2 (fr) |
BR (1) | BRPI0512869A (fr) |
CA (1) | CA2603249C (fr) |
IL (1) | IL180977A (fr) |
NO (1) | NO20071102L (fr) |
NZ (1) | NZ552806A (fr) |
RU (1) | RU2007107494A (fr) |
TW (1) | TWI377195B (fr) |
WO (1) | WO2007081299A2 (fr) |
ZA (1) | ZA200700684B (fr) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2603249C (fr) | 2004-07-29 | 2014-01-21 | Athersys, Inc. | Derives d'indenopyrrole tricycliques utilises en tant que modulateurs des recepteurs de la serotonine |
EP2018863B9 (fr) | 2006-05-16 | 2015-02-18 | Takeda Pharmaceutical Company Limited | Composé hétérocyclique fusionné et utilisation |
EP1988091B1 (fr) | 2007-02-07 | 2015-06-10 | Kyowa Hakko Kirin Co., Ltd. | Composés tricycliques |
US20100266504A1 (en) | 2007-11-15 | 2010-10-21 | Takahiro Matsumoto | Condensed pyridine derivative and use thereof |
WO2009097995A1 (fr) * | 2008-02-07 | 2009-08-13 | Sanofi-Aventis | Nouvelles imidazolidines substituées par un phényle, procédé de production, médicaments contenant ces composés et leur utilisation |
WO2010016549A1 (fr) * | 2008-08-06 | 2010-02-11 | 協和発酵キリン株式会社 | Composé tricyclique |
TW201041851A (en) | 2009-03-10 | 2010-12-01 | Organon Nv | Tricyclic heterocyclic derivatives |
US8871758B2 (en) | 2011-03-08 | 2014-10-28 | Sanofi | Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof |
US8828995B2 (en) | 2011-03-08 | 2014-09-09 | Sanofi | Branched oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
WO2012120052A1 (fr) | 2011-03-08 | 2012-09-13 | Sanofi | Dérivés d'oxathiazine substitués par des carbocycles ou des hétérocycles, leur procédé de préparation, médicaments contenant ces composés et leur utilisation |
EP2683699B1 (fr) | 2011-03-08 | 2015-06-24 | Sanofi | Dérivés oxathiazine di- et tri-substitués, procédé pour leur préparation, utilisation en tant que médicament, agent pharmaceutique contenant ces dérivés et utilisation |
WO2012120054A1 (fr) | 2011-03-08 | 2012-09-13 | Sanofi | Dérivés oxathiazine di- et tri-substitués, procédé pour leur préparation, utilisation en tant que médicament, agent pharmaceutique contenant ces dérivés et utilisation |
CN106380440B (zh) * | 2016-08-30 | 2019-02-01 | 华东师范大学 | 一种茚酮并吡咯类衍生物及其合成方法和应用 |
CN106631989B (zh) * | 2016-11-26 | 2019-07-16 | 威海迪素制药有限公司 | 一种盐酸多奈哌齐有关物质e的制备方法 |
JPWO2019131902A1 (ja) | 2017-12-27 | 2020-12-10 | 武田薬品工業株式会社 | 腹圧性尿失禁および便失禁の治療薬 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4622405A (en) * | 1984-07-25 | 1986-11-11 | Abbott Laboratories | 1,2,3,3a,8,8a-hexahydro-indeno[1,2-c]pyrroles useful in the treatment of hypertension |
EP0170093B1 (fr) * | 1984-07-25 | 1990-03-07 | Abbott Laboratories | 1,2,3,3a,8,8a-Hexahydro-Indéno-(1,2-c)Pyrroles |
WO1990006927A1 (fr) * | 1988-12-15 | 1990-06-28 | Abbott Laboratories | Agents selectifs de 5-ht |
US5049564A (en) * | 1989-11-17 | 1991-09-17 | Abbott Laboratories | 5-HT selective agents |
US5244888A (en) * | 1989-11-17 | 1993-09-14 | Abbott Laboratories | 5-HT selective agents |
TW334423B (en) * | 1993-10-22 | 1998-06-21 | Hoffmann La Roche | Tricyclic 1-aminoethylpyrrole-derivatives |
US7351711B2 (en) * | 2003-07-31 | 2008-04-01 | Janssen Pharmaceutical, N.V. | Tricyclic indanyls as integrin inhibitors |
TWI350168B (en) * | 2004-05-07 | 2011-10-11 | Incyte Corp | Amido compounds and their use as pharmaceuticals |
CA2603249C (fr) * | 2004-07-29 | 2014-01-21 | Athersys, Inc. | Derives d'indenopyrrole tricycliques utilises en tant que modulateurs des recepteurs de la serotonine |
-
2005
- 2005-07-26 CA CA2603249A patent/CA2603249C/fr not_active Expired - Fee Related
- 2005-07-26 NZ NZ552806A patent/NZ552806A/en not_active IP Right Cessation
- 2005-07-26 KR KR1020077002230A patent/KR101257233B1/ko not_active IP Right Cessation
- 2005-07-26 KR KR1020137007788A patent/KR20130047765A/ko not_active Application Discontinuation
- 2005-07-26 CN CNA2005800255071A patent/CN101516372A/zh active Pending
- 2005-07-26 WO PCT/US2005/026415 patent/WO2007081299A2/fr active Application Filing
- 2005-07-26 EP EP05858534A patent/EP1841738A4/fr not_active Withdrawn
- 2005-07-26 BR BRPI0512869-2A patent/BRPI0512869A/pt not_active Application Discontinuation
- 2005-07-26 AU AU2005333518A patent/AU2005333518B2/en not_active Ceased
- 2005-07-26 JP JP2007554065A patent/JP4990164B2/ja not_active Expired - Fee Related
- 2005-07-26 US US11/189,952 patent/US20060025601A1/en not_active Abandoned
- 2005-07-26 RU RU2007107494/04A patent/RU2007107494A/ru not_active Application Discontinuation
- 2005-07-28 AR ARP050103146A patent/AR050274A1/es not_active Application Discontinuation
- 2005-07-29 TW TW094125988A patent/TWI377195B/zh not_active IP Right Cessation
-
2007
- 2007-01-24 ZA ZA200700684A patent/ZA200700684B/xx unknown
- 2007-01-25 IL IL180977A patent/IL180977A/en not_active IP Right Cessation
- 2007-02-27 NO NO20071102A patent/NO20071102L/no not_active Application Discontinuation
-
2009
- 2009-06-04 US US12/478,362 patent/US7935830B2/en not_active Expired - Fee Related
-
2011
- 2011-03-25 US US13/071,732 patent/US8232311B2/en not_active Expired - Fee Related
-
2012
- 2012-06-18 US US13/526,249 patent/US8716324B2/en not_active Expired - Fee Related
-
2014
- 2014-03-21 US US14/221,809 patent/US9096520B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200700684B (en) | Tricyclic indeno-pyrrole derivatives as serotonin receptor modulators | |
IL179278A0 (en) | Substituted azepine derivatives as serotonin receptor modulators | |
HUS1700010I1 (hu) | Új vegyületek mint ópioid receptor modulátorok | |
ZA200709819B (en) | Tricyclic spiro derivatives as CRTH2 modulators | |
PL1833799T3 (pl) | 3-Fenylo-pirazolowe pochodne jako modulatory 5-HT2A receptora serotoniny użyteczne w leczeniu zaburzeń związanych z tym receptorem | |
PT1668014E (pt) | Compostos heterocíclicos fundidos como moduladores do receptor de serotonina | |
GB0400440D0 (en) | Receptor modulators | |
IL178767A0 (en) | Indolyl derivatives as liver - x - receptor modulators | |
EP1890696A4 (fr) | Nouveaux derives 3-spirocyclique indolyle utiles comme modulateurs du recepteur orl-1 | |
EP1799640A4 (fr) | Composes indole convenant comme agents selectifs par rapport a la serotonine | |
IL181120A0 (en) | Tricyclic ?? -opioid modulators | |
EP1670483A4 (fr) | Derives de 4-azasteroide 17-heterocycliques servant de modulateurs du recepteur d'androgene | |
PL1828194T3 (pl) | Tetracykliczne imidazo-benzodiazepiny jako modulatory receptorów GABA | |
IL180637A0 (en) | Tricyclic pyrazole derivatives as cannabinoid receptor modulators | |
EP1663228A4 (fr) | Utilisation de derives 17-heterocycliques-4-azasteroidiens comme modulateurs du recepteur des androgenes | |
ZA200800689B (en) | Benzofuranone derivatives as nonsteroidal progesterone receptor modulators | |
EP1641535A4 (fr) | Derives de 17-acetamido-4-azasteroide en tant que modulateurs du recepteur d'androgene | |
IL188924A0 (en) | Imidazopyridine derivatives as cannabinoid receptor ligands | |
IL184532A0 (en) | Novel adenosine a3 receptor modulators | |
EP1641464A4 (fr) | Derives de 17-acetamido-4-azasteroides servant de modulateurs du recepteur d'androgenes | |
EP1696925A4 (fr) | Derives d'azasteroide-4 heterocycliques-21 en tant que modulateurs du recepteur d'androgene | |
EP1641761A4 (fr) | Derives de 17-acetamido-4-azasteroide servant de modulateurs du recepteur d'androgenes | |
ZA200800354B (en) | Imidazopyridine derivatives as cannabinoid receptor ligands | |
ZA200703885B (en) | 3-phenyl-pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto |